CA2099117A1 - Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion - Google Patents
Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretionInfo
- Publication number
- CA2099117A1 CA2099117A1 CA002099117A CA2099117A CA2099117A1 CA 2099117 A1 CA2099117 A1 CA 2099117A1 CA 002099117 A CA002099117 A CA 002099117A CA 2099117 A CA2099117 A CA 2099117A CA 2099117 A1 CA2099117 A1 CA 2099117A1
- Authority
- CA
- Canada
- Prior art keywords
- salts
- inhibitors
- amino
- salt
- acid secretion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919101918A GB9101918D0 (en) | 1991-01-29 | 1991-01-29 | Compound |
| GB919101919A GB9101919D0 (en) | 1991-01-29 | 1991-01-29 | Compound |
| GB9101918.2 | 1991-01-29 | ||
| GB9101919.0 | 1991-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2099117A1 true CA2099117A1 (en) | 1992-07-30 |
Family
ID=26298350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002099117A Abandoned CA2099117A1 (en) | 1991-01-29 | 1992-01-27 | Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0569396A1 (fi) |
| JP (1) | JPH06504541A (fi) |
| CN (1) | CN1064268A (fi) |
| AP (1) | AP337A (fi) |
| AU (1) | AU652028B2 (fi) |
| CA (1) | CA2099117A1 (fi) |
| CZ (1) | CZ153293A3 (fi) |
| FI (1) | FI933376A (fi) |
| HU (1) | HUT67609A (fi) |
| IE (1) | IE920267A1 (fi) |
| IL (1) | IL100791A0 (fi) |
| MA (1) | MA22401A1 (fi) |
| MX (1) | MX9200338A (fi) |
| NO (1) | NO932722D0 (fi) |
| NZ (1) | NZ241408A (fi) |
| PT (1) | PT100056A (fi) |
| SK (1) | SK70993A3 (fi) |
| WO (1) | WO1992012969A1 (fi) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9126438D0 (en) * | 1991-12-12 | 1992-02-12 | Smithkline Beecham Intercredit | New quinoline derivatives |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| USRE43932E1 (en) | 1997-07-18 | 2013-01-15 | Novartis Ag | Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| AU2002342917A1 (en) * | 2001-11-19 | 2003-06-10 | Altana Pharma Ag | Reversible proton pump inhibitors for the treatment of airway disorders |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| EP1534278A4 (en) | 2002-08-01 | 2006-09-06 | Nitromed Inc | NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD |
| EP1682133A1 (en) | 2003-11-03 | 2006-07-26 | AstraZeneca AB | Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8804444D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
-
1992
- 1992-01-27 CA CA002099117A patent/CA2099117A1/en not_active Abandoned
- 1992-01-27 NZ NZ241408A patent/NZ241408A/en unknown
- 1992-01-27 WO PCT/EP1992/000200 patent/WO1992012969A1/en not_active Application Discontinuation
- 1992-01-27 SK SK709-93A patent/SK70993A3/sk unknown
- 1992-01-27 EP EP92903019A patent/EP0569396A1/en not_active Withdrawn
- 1992-01-27 MA MA22687A patent/MA22401A1/fr unknown
- 1992-01-27 CZ CZ931532A patent/CZ153293A3/cs unknown
- 1992-01-27 MX MX9200338A patent/MX9200338A/es unknown
- 1992-01-27 AP APAP/P/1992/000352A patent/AP337A/en active
- 1992-01-27 JP JP4503051A patent/JPH06504541A/ja active Pending
- 1992-01-27 AU AU11799/92A patent/AU652028B2/en not_active Ceased
- 1992-01-27 HU HU9302201A patent/HUT67609A/hu unknown
- 1992-01-28 IE IE026792A patent/IE920267A1/en unknown
- 1992-01-28 PT PT100056A patent/PT100056A/pt not_active Application Discontinuation
- 1992-01-28 CN CN92101029A patent/CN1064268A/zh active Pending
- 1992-01-28 IL IL100791A patent/IL100791A0/xx unknown
-
1993
- 1993-07-28 FI FI933376A patent/FI933376A/fi unknown
- 1993-07-28 NO NO932722A patent/NO932722D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL100791A0 (en) | 1992-09-06 |
| CZ153293A3 (en) | 1993-12-15 |
| WO1992012969A1 (en) | 1992-08-06 |
| IE920267A1 (en) | 1992-07-29 |
| CN1064268A (zh) | 1992-09-09 |
| FI933376A0 (fi) | 1993-07-28 |
| MA22401A1 (fr) | 1992-10-01 |
| AU652028B2 (en) | 1994-08-11 |
| AU1179992A (en) | 1992-08-27 |
| HUT67609A (en) | 1995-04-28 |
| PT100056A (pt) | 1993-03-31 |
| EP0569396A1 (en) | 1993-11-18 |
| HU9302201D0 (en) | 1993-10-28 |
| NO932722L (no) | 1993-07-28 |
| FI933376A (fi) | 1993-07-28 |
| NZ241408A (en) | 1994-05-26 |
| AP9200352A0 (en) | 1992-01-31 |
| NO932722D0 (no) | 1993-07-28 |
| AP337A (en) | 1994-04-08 |
| SK70993A3 (en) | 1994-01-12 |
| JPH06504541A (ja) | 1994-05-26 |
| MX9200338A (es) | 1992-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1399161B1 (en) | Sustained-release analgesic compounds | |
| JP4045070B2 (ja) | キノリン誘導体 | |
| JP3950337B2 (ja) | 悪性腫瘍治療薬 | |
| US2918408A (en) | Anti-spasmodic compositions specific for treating spasm of the colon | |
| KR100704152B1 (ko) | ＮＦ-κＢ 저해제를 유효 성분으로 하는 심근염, 확장형 심근증 및 심부전의 예방제 또는 치료제 | |
| JPH08268890A (ja) | Ｃ型肝炎の予防・治療剤 | |
| AP337A (en) | Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. | |
| JP2502343B2 (ja) | 薬学的に活性な置換ベンズアミド | |
| JP2672101B2 (ja) | キサンテノン−４−酢酸誘導体 | |
| WO1997032863A1 (fr) | Derives de thiazolidine-2,4-dione | |
| JPH0430924B2 (fi) | ||
| EP1097924B1 (en) | 4-hydroxy-4-phenylpiperidine derivatives having opioid agonist activity and pharmaceuticals containing the same | |
| GB2024011A (en) | Use of arylamino benzoic acids as hypoglycemic agents and pharmaceutical compositions for said use | |
| JP2974351B2 (ja) | プロドラッグとしての６―クロロ―７，８―ジヒドロキシ―１―（４’―ヒドロキシフェニル）―２，３，４，５―テトラヒドロ―１ｈ―３―ベンズアゼピンのカルバメート | |
| US4252818A (en) | Novel benzopyran derivatives | |
| RU2236407C2 (ru) | Производные пиримидина | |
| GB2193210A (en) | Glycine derivatives | |
| JPH069402A (ja) | 抗潰瘍剤 | |
| JPH0521890B2 (fi) | ||
| EP1749817A1 (en) | Neurogenic pain control agent composition | |
| KR20010022833A (ko) | 2-｛3-[4-(2-ｔ-부틸-6-트리플루오로메틸피리미딘-4-일)피페라진-1-일]프로필머캅토｝피리미딘-4-올-푸마레이트 | |
| HU183555B (en) | Process for preparing n-/1-allyl-2-pyrrolidinyl-methyl/-2-methoxy-4-amino-5-methyl-sulphamoyl-benzamide | |
| JPS6130588A (ja) | ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤 | |
| JPH0517442A (ja) | ピペリジン誘導体 | |
| JPS6350327B2 (fi) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |